Our results support the hypothesis that mutations in the gene for PAX3 can pre dispose to NTD, but also show that, in general, m utations within or near the con served domains o f the PAX3 protein are only very infrequently involved in fam ilial NTD. (J Med Genet 1995; 32:52-56) which is expressed in defined regions of the developing neural tube and in various neural crest derived tissues,7 can cause N T D in ho mozygous embryos. 8 In the heterozygous state, Pax3 mutations do not cause but seem to pre dispose to N T D in a strain specific manner.9 10 A similar situation may exist in humans, where mutations in the PAX3 gene are known to cause Waardenburg syndrome (WS) , 11M7 a condition which is occasionally associated with N T D .18-24 Therefore, it is tempting to speculate that in man, too, mutations in the gene for PAX3 (also referred to as HuP2) constitute genetic risk factors for N T D . If so, their frequency should be increased in patients with this disorder.
M aterials and m ethods
ASCERTAINMENT OF PATIENTS AND DNA ISOLATION Patients were selected from the Dutch popu lation in collaboration with the patient or ganisation BOSK and from the records of the Nijmegen hospital departments. Thirty nine families were selected with more than one pa tient who had an affected third degree or closer relative (first cousin, great aunt, or great uncle of the proband).3 Genomic DNA was isolated from one patient from every family according to the procedure of Miller et a i 25 The types of NTD in the test patients were spina bifida (37), encephalocele (1), and craniorachischisis ( 1).
Neural tube defects (NTD) are congenital mal formations resulting from incomplete closure of the neural tube during early embryonic de velopment. In man, their prevalence at birth is about 1/ 1000. NTD are thought to result from an interaction between environmental and pre disposing genetic factors which interfere with the normal neurulation process.1 The in volvement of genetic factors is reflected by the increased recurrence risk for close relatives of patients. Only about 3% of all cases are familial and large families with multiple cases are ex tremely rare.23 Therefore, it is practically im possible to identify the underlying genetic factors by linkage studies.4 Elucidation of these factors is essential to understanding the patho genesis of NTD and for the identification of persons at risk of having affected offspring.
An alternative approach to shed more light on these genetic factors is the analysis of suitable animal models. In one of the models for NTD, Splotch, 15 mutations in the gene for Pax3, 6 SSC ANALYSIS DNA fragments overlapping exons 2 to 6 of the human PAX3 gene were amplified by the polymerase chain reaction (PCR) from gen omic DNA together with 5' and 3' flanking intron sequences. Amplification was carried out in a total volume of 25 jil containing 50 ng of genomic DNA, 0*45 mmol/1 of each primer, 0-1 mmol/1 dCTP3 0-4 mmol/1 dATP, 0'4 mmol/ 1 dGTP, 0 -4 mmol/1 dTTP, 0-1 jil [a32P]dCTP (Amersham) in PCR buffer (50 mmol/1 KC1, 10 mmol/1 Tris-HCl, pH 8-3, 1 mmol/1 DTE, 0 *001% gelatine, 1-5-6 mmol/1 MgCl2) with 0*5 U Taq DNA polymerase (Boehringer Mannheim). Samples were denatured at 92°C for five minutes and then subjected to 35 cycles of amplification: 92°C for 50 seconds, 55°C for 50 seconds, 72°C for one minute 30 sec onds. Exon 2 was analysed as two partly over lapping fragments. The following primers were used for amplification ( fig 1) , some of which are identical to those reported by Tassabehji et 
GACCACAGTCTGGGAGCCAGGAGG-3'; exon 3 (237 bp): 5'-CACCTGGCCC-AGGGTACCGGGTAC-3' and 5'-CGGGG~ TAÄTAGCGACTGACTGTC-3'; exon 4 (242 bp): 5 AGCCCTGCTTGTCTCAAC-CATGTG-3' and 5'-TGCCCTCCAAGT-CACCCAGCAAGT-3'; exon 5 (304 bp): 5'-GACTTGGATCAATCTCAGTTTT-3' and 5 '-TAGGAC A C G G AG G TTT G G-3 exon 6 (250 bp) 5'-TT CAT C AGTGAAAT C CTT -AAATT-3' and 5'-CGCCTGGAAGTTACT-TTCTA-3'. Aliquots of the amplified D N A
were mixed with one volume form amide dye buffer denatured at 95°C for five minutes3 and placed on ice; 4 j.il samples were loaded on a 5% non-denaturing polyacrylamide gel containing 10% glycerol and on a similar gel without glycerol. Electrophoresis was for three to six hours at 35W and 5°C. The gels were dried and exposed overnight to Kodak X-omat S film in order to visualise the separate bands.
DIRECT SEQUENCING OF N O RM A L M UTANT

ALLELES
To determine the nature of the shifted bands in the SSC analysis, 4 \û of amplification prod uct was loaded on a 6 *6 % denaturing poly acrylamide gel. The gel was electrophoresed at 60 W for three hours at room temperature, dried, and exposed overnight to Kodak X-omat S film to visualise the bands. Bands rep resenting wild type and mutant alleles were cut out of the gel. DNA was eluted from each of the gel slices in 50 pi distilled water for one hour at 37°C and reamplified under the conditions described above. Subsequently, the amplified DNA fragments were purified by electro phoresis on a 1% agarose gel (one hour, 10 V/ cm), allowed to migrate into ultra low gelling temperature agarose (Sigma) , and sliced out of the gel. This material served as substrate for direct sequencing using the Cycle Sequence Kit (BRL) according to the protocol of the manufacturer. Sequences were determined in two directions with the forward and reverse amplification primers after 5' end labelling with 
D iscu ssion The association between N T D and WS is well documented. Interestingly* of the 11 patients with NTD and WS reported since 1988* eight represent familial cases of N T D .19"24
This in cludes the index patient of the present study* who had a maternal aunt with spina bifida. Apparently* there is an increased recurrence risk of N TD in families with WS* which cor roborates the common aetiology of both dis orders. The molecular defect in two other patients with WS and N T D has previously been reported.1215 Both cases concern missense mutations in exon 2 changing an amino acid within the paired domain of the PAX3 protein. Here we show that mutations disrupting the open reading frame of the PAX3 gene may also be found in patients with WS and NTD. Despite the fact that carriers of a PAX3 mutation probably have an increased risk for NTD* in the present study only one of 39 patients with familial N T D was found to have such a mutation indicating that* in general* PAX3 mutations are an infrequent cause of familial N TD . However* SSC analysis is not completely sensitive* leaving the possibility that some mutations have not been detected by this method. Further* mutations could be present in exons 1* 7* or 8* which have not yet been examined in detail. Nevertheless* mutations within or near the conserved domains of the PAX3 protein are not likely to play a major role in familial NTD.
Because of the findings in Splotch mice* it is not surprising that N T D may be present in humans carrying a mutation in the PAX3 gene. Homozygous Splotch embryos die on day 13 of gestation and 50% have lumbosacral spina bifida. Heterozygous animals display pig mentary disturbances* but have a normally closed neural tube* yet breeding experiments have shown that a heterozygous Pax3 mutation influences the incidence of N T D in animals already committed to N T D development.9 10 Apparently* in those animals the occurrence of N T D depends on a combination of pre determining factors. A similar situation may exist in humans* where additional factors may modify the phenotypic expression of the same PAX3 mutation in different persons. Spina bifida is not the only malformation of homozygous Splotch embryos. In 50% exencephaly is observed and congenital heart de fects also occur* which are regarded as the major cause of death. In humans* anencephaly and congenital heart defects do not seem to be associated with WS but* considering the influence of other genetic factors on the pheno type* it may be worth looking for PAX3 mut ations in patients with NTD and congenital heart defects.
The pathophysiological processes leading to N TD in Splotch have not yet been elucidated, Suggested mechanisms include delayed mi gration of neural crest cells and an abnormal curvature of the caudal region. More likely* these phenomena are secondary to a defect of the neuroepithelium* where the Pax3 gene is expressed before neural tube closure.10 The detection and functional characterisation of PAX3 gene mutations in patients with N TD may help to clarify the pathogenesis of N TD further.
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